Photo for representational purpose only. Reuters file
December 23
A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.
After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus’s Delta variant after two doses, the company added.
The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca. Reuters
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
9 burnt to death as bus carrying devotees from Punjab catches fire near Tauru in Haryana
Devotees were returning from pilgrimage to Mathura and Vrind...
AAP releases Swati Maliwal's new video walking out of Arvind Kejriwal's residence
Swati Maliwal said that her clothes were torn, and she recei...
South Asian students attacked in Kyrgyzstan’s Bishkek; EAM Jaishankar, Pakistani counterpart advise students to stay indoors
Videos shows Asian looking youngsters being cornered by loca...
Girl among 4 law students killed as their speeding SUV crashes near university in Punjab's Patiala
The impact of the collision was so intense that police had t...
Rajya Sabha MP Swati Maliwal facing corruption case, blackmailed by BJP to be part of conspiracy against CM Kejriwal: AAP
‘Maliwal is facing charges in an illegal recruitment case re...
